News Hub | News Direct

Healthcare

Addiction Biotech Cannabis Genetics Healthcare Medical Devices Pharmaceutical Science Veterinary
Article thumbnail News Release

Roberts & Ryan Inc., America's first Service-Disabled Veteran-Owned broker-dealer, is honored as a 2023 VETS Indexes 5 Star Employer

Roberts & Ryan Investments, Inc.

Roberts & Ryan, Inc. has earned the VETS Indexes 5 Star Employer designation in the 2023 VETS Indexes Employer Awards. The award recognizes the organization’s commitment to recruiting, hiring, retaining, developing, and supporting veterans and the military-connected community. “Roberts & Ryan Investments, Inc. stands out from the pack as one of the best employers nationwide for veterans, members of the National Guard and Reserves, and military spouses,” said George Altman, managing director of VETS Indexes. “As more and more employers recognize the cutting-edge technical skills and soft skills veterans bring to the workplace, the race to attract military-connected talent gets increasingly competitive. The number of organizations participating in the 2023 VETS Indexes Employer Awards more than doubled since last year – but even in this highly competitive environment, Roberts & Ryan Investments, Inc. distinguished itself as a leader among veteran employers and should be commended,” Altman said. “We are honored to have been selected for the VETS Index’s 5 Star Employer Rating. Our Nation’s Veterans have tremendous skills acquired while they served to protect our freedoms. When given the opportunity to reframe their skills from military to civilian service great things happen. The combination of these skills and their mission first perspective is an asset to any organization in any field. We challenge all corporations to look beyond a Veterans’ DD-214s and embrace how they can become valued employees to any company,” said Brian Rathjen, President of Roberts & Ryan. This year, a record number of 239 organizations participated in the VETS Indexes Employer Awards, more than double the 118 participants in 2022. Of those, VETS Indexes recognized 200 organizations across the following award levels: 5 Star Employer, 4 Star Employer, 3 Star Employer, and Recognized Employer. Not every responding organization made the cut – only those that demonstrated a strong commitment to veterans, members of the National Guard and Reserves, and military spouses. Participating organizations included companies large and small, government agencies and departments, nonprofit groups, colleges, and universities. As the most objective and comprehensive evaluation of veteran employers, the VETS Indexes Employer Awards program has set a new standard in veteran employment data. Their award results have been featured on CNBC, as well as military-specific outlets, including Military.com. Click this link to see the full slate of awardees: https://vetsindexes.com/award-results-2023 About Roberts and Ryan, Inc. Roberts & Ryan, Inc. is a Service-Disabled Veteran Owned (SDVO) broker-dealer with execution capabilities in the capital markets, equities, and fixed-income trading. The firm was founded in 1987 by a United States Marine Corps Vietnam combat veteran and Purple Heart recipient. With over one million dollars in committed donations, Roberts & Ryan is active in donating to charitable foundations that make significant positive impacts in the lives of Veterans and their families, primarily focusing on general wellness, mental health, and career transition. Contact Details Roberts & Ryan, Inc. Michael C. Del Priore +1 646-859-4061 mdelpriore@roberts-ryan.com Company Website https://www.roberts-ryan.com

April 14, 2023 09:00 AM Eastern Daylight Time

Article thumbnail News Release

Branded Legacy, Inc. Announces 2022 Revenues Surpass 2021 by Over 335%

BRANDED LEGACY INC.

McapMediaWire -- Branded Legacy, Inc. (OTC: BLEG ), a holding company specializing in growth through acquisitions with a focus on the CBD industry, announced today that its 2022 revenues surpassed 2021 by over 335%. The company's subsidiaries have made significant strides, and 2023 is expected to set record revenues for the company. "This is a tremendous achievement for Branded Legacy, and we are proud to see our hard work paying off," said Jermain Strong, the CEO of Branded Legacy. "We have been committed to driving growth and profitability in the CBD industry, and our efforts are starting to pay dividends. The CBD industry is expected to continue its growth trajectory, and we are well-positioned to take advantage of this trend." Branded Legacy's subsidiaries have contributed significantly to the company's revenue growth. The company's acquisition of a CBD brand in early 2022 has proven to be a successful move, with the brand's products experiencing strong demand in the market. The company's other subsidiaries have also performed well, contributing to the overall revenue growth. "We have a clear strategy in place to continue our growth trajectory and further increase our market share," said Strong. "We will continue to seek out acquisition opportunities and invest in our subsidiaries to ensure they have the resources they need to succeed." Branded Legacy expects 2023 to be another record year for the company, with continued revenue growth and profitability. About Versatile Industries: Versatile Industries, LLC is an acquisition company used to incubate companies to eventually spin off into their own public vehicles. About Alpha Growers, LLC: Alpha Growers, LLC is a hemp farm in Newberry, FL. They grow and sell hemp flower, providing some of the highest quality plants in the industry. Its current operations are under Kamino Propagation and Research, LLC. Currently Alpha Growers has $320,000 in assets and is in contract to purchase the remaining assets of Kamino over the next few years. About Total Refinement Solutions, LLC: Total Refinement Solutions, LLC has developed no less than four potential standard operating procedures for extraction, refinement and synthesis of any given target alkaloid. It has secured inputs of raw plant material, crude extracts for refinement and a demand for the output. The Company currently has operational labware as assets. Safe Harbor Statement: The information posted in this release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements by the use of the words "may," "will," "should," "plans," "expects," "anticipates," "continue," "estimate," "project," "intend," and similar expressions. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected or anticipated. These risks and uncertainties include, but are not limited to, general economic and business conditions, effects of continued geopolitical unrest and regional conflicts, competition, changes in technology and methods of marketing, delays in completing various engineering and manufacturing programs, changes in customer order patterns, changes in product mix, continued success in technological advances and delivering technological innovations, shortages in components, production delays due to performance quality issues with outsourced components, and various other factors beyond the Company's control. www.brandedlegacy.com (407) 337-0642 info@brandedlegacy.com Contact Details Branded Legacy, Inc. info@brandedlegacy.com

April 14, 2023 08:30 AM Eastern Daylight Time

Article thumbnail News Release

Voyageur Pharmaceuticals' SmoothX abdominal diagnostic drink gets high praise in comparative study

Voyageur Pharmaceuticals Ltd

Voyageur Pharmaceuticals CEO Brent Willis joins Proactive's Natalie Stoberman to share the latest results from its SmoothX comparative studies. Willis says results of the double-blind testing showed that SmoothX was favoured on drinkability and taste by 75% of patients compared to the competing product. Before SmoothX goes to market, Willis adds a medical white paper is currently in preparation that will provide an in-depth analysis of the studies and insights into the effectiveness of SmoothX to educate and inform doctors and medical staff about the product's benefits for abdominal CT diagnostic imaging procedures. Contact Details Proactive Investors +1 604-688-8158 na-editorial@proactiveinvestors.com

April 13, 2023 01:48 PM Eastern Daylight Time

Video
Article thumbnail News Release

Bringing Dialysis Home with the Tablo® Hemodialysis System

YourUpdateTV

A video accompanying this announcement is available at: https://youtu.be/Mqq3M7o4YZ8 Living with kidney disease is hard. While the treatment is life-saving, it is also life-changing, forcing patients to fit their lives into their dialysis schedules. For patients like David Rush, it meant going into a dialysis center for five hours, three days a week, forcing him to fit his life around his dialysis schedule. As a touring musician, this rigid schedule didn’t work. Outset Medical, creator of the Tablo® Hemodialysis System, teamed up with David Rush on a nationwide media tour to discuss his kidney health journey and experiences treating in clinic and at home. Dialysis is one of the largest, most expensive, least-changed healthcare sectors, even though half a million Americans depend on dialysis to live. Despite the huge expense and burden on providers and patients, dialysis has seen virtually no innovation over the last 30 years. Until Tablo, an easy-to-learn, all-in-one dialysis device that allows for dialysis to be delivered anytime, anywhere and by virtually anyone. Tablo is FDA-cleared for use in many settings, from hospital to home. The intuitive, interactive touchscreen displays 3-D animations and conversational instructions to simplify system set-up, treatment and alarm resolution. With the help of Tablo, David is dialyzing at home, on his schedule, and has been able to build his life around what matters most to him: his family, music career and kidney disease advocacy efforts. The ease of use has provided David with the flexibility to choose when and how he receives treatment, even when he’s on the road touring. FOR MORE INFORMATION VISIT: WWW.TABLOHOMENOW.COM Contact Details YourUpdateTV +1 212-736-2727 yourupdatetv@gmail.com

April 13, 2023 10:39 AM Eastern Daylight Time

Video
Article thumbnail News Release

Immunic gets a "positive surprise" from lead asset trial

Immunic Inc

Immunic Inc (NASDAQ:IMUX) CEO Dr. Daniel Vitt speaks to Proactive following the release of data from the maintenance phase of its phase 2b CALDOSE-1 trial of lead asset vidofludimus calcium (IMU-838) in patients with moderate-to-severe ulcerative colitis (UC). Vitt describes it as "wonderful data" that came as a "positive surprise." Contact Details Proactive United States Proactive United States +1 347-449-0879 action@proactiveinvestors.com

April 13, 2023 08:00 AM Eastern Daylight Time

Video
Article thumbnail News Release

Oxford Cannabinoid Technologies confirms Sowemimo-Coker as permanent CEO

Oxford Cannabinoid Technologies Holdings PLC

Oxford Cannabinoid Technologies Holdings PLC (LSE:OCTP, OTCQB:OCTHF) CEO Clarissa Sowemimo-Coker speaks to Proactive after the pharmaceutical group confirmed that she has now taken on the role on a permanent basis, having been appointed on an interim basis in December 2022. Sowemimo-Coker highlights the ongoing work on four drug development programs, including awaiting approval from MHRA for the lead program targeting chemotherapy induced peripheral neuropathy. Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

April 13, 2023 07:37 AM Eastern Daylight Time

Video
Article thumbnail News Release

NanoViricides using unique technology platform to fight against viruses

NanoViricides

NanoViricides CEO Anil Diwan joined Steve Darling from Proactive to share news about the company that is using its nanoviricide platform technology to develop drugs that fight against viruses. Diwan tells Proactive some of the drugs in development include its most advanced which deals with shingles. The company is also looking at cold sores, influenza, genital lesions, rabies and Ebola. Diwan also shared with Proactive the company has signed a licensing agreement with Karveer Meditech in India for the right to commercialize the company's COVID drugs NV-CoV-2 and NV-CoV-2-R. Contact Details Proactive Investors +1 604-688-8158 na-editorial@proactiveinvestors.com

April 12, 2023 01:59 PM Eastern Daylight Time

Video
Article thumbnail News Release

Software Effective Solutions "MEDCANA" (OTC: SFWJ) Provides Corporate Update for Shareholders

Software Effective Solutions Corp.

McapMediaWire -- Software Effective Solutions, (OTC: SFWJ ) (“The Company”, “SFWJ”) dba MedCana, is a global holding company focused on acquiring and developing companies in the cannabis industry with initial focus in Central and South America, announces today that MedCana has commenced the construction of infrastructure for its five cannabis production companies located in Colombia. The first phase of the infrastructure development project will involve the construction of roads and the preparation of installation for water tanks and rainwater collection systems. Last week, earth moving machinery was put into action to create access to all five companies, covering 100 acres of land. Fencing and delimitation of the individual companies have been completed, and the focus has shifted towards ensuring stable roads and managing water runoff to capture rainwater and prevent property erosion due to the high volume of rainwater. J. Gabriel Diaz, CEO of MedCana states: “MedCana is committed to collecting and utilizing rainwater for the irrigation of all production for the five companies. With an average rainfall of 29 inches, water can quickly become a problem, washing away roads and causing damage to greenhouses. This is why the first phase of the project is of utmost importance.” ABOUT SFWJ: Software Effective Solutions/MedCana is a global infrastructure and holding company in the cannabis industry. Currently, MedCana has five companies focused on pharmaceutical cannabis production, one software company focused on managing processes for plant-to-patient operations. The recent acquisition an irrigation and greenhouse technology company has rounded out MedCana’s portfolio of companies. MedCana's initial focus is on developing clients and companies in Latin America with an initial focus in Colombia and partnerships with laboratories, research facilities, and hospitals throughout the world. SAFE HARBOR STATEMENT This press release contains forward-looking statements that can be identified by terminology such as "believes," "expects," "potential," "plans," "suggests," "may," "should," "could," "intends," or similar expressions. Many forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results implied by such statements. These factors include, but are not limited to, our ability to continue to enhance our products and systems to address industry changes, our ability to expand our customer base and retain existing customers, our ability to effectively compete in our market segment, the lack of public information on our company, our ability to raise sufficient capital to fund our business, operations, our ability to continue as a going concern, and a limited public market for our common stock, among other risks. Many factors are difficult to predict accurately and are generally beyond the company's control. Forward-looking statements speak only as to the date they are made, and we do not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made. Contact: Jose Gabriel Diaz, CEO www.medcana.net info@medcana.co Contact Details MedCana info@medcana.co Company Website https://www.medcana.net/

April 12, 2023 09:00 AM Eastern Daylight Time

Article thumbnail News Release

Right On Brands Acquires 49% Interest in Neuro Science Research Centers

Right On Brands, Inc.

McapMediaWire -- Right on Brands, Inc. (OTC: RTON ), a leader and innovator of HEMP DERIVED, and WELLNESS products announced today that its Board of Directors has approved an investment in Neuro Science Research Centers Inc. Neuro Science Research Centers Inc. was formed to be one of the first licensed Psilocybin extraction facilities in Oregon. Psilocybin is being used to treat mental disorders and is shown to be of great benefit. The Johns Hopkins Center for Psychedelic and Consciousness Research is leading the way in exploring innovative treatments using psilocybin. The molecular structure of psilocybin, a naturally occurring psychedelic compound found in 'magic mushrooms,' allows it to penetrate the central nervous system and the scientific and medical experts are just beginning to understand its effects on the brain and mind and its potential as therapeutics for mental illnesses. Many other researchers and companies are looking to use these new products that will come from Psilocybin. Jerry Grisaffi, President, and CEO of Right on Brands, stated, “We are excited to be entering into this relationship and partnership with Neuro Science Research Centers. Psilocybin research is still in its infancy, but with the level of production already accomplished and continued acceptance within the medical community using psilocybin, we believe this is an opportunity for us to be on the ground level, yet with our locations and distribution network we will be able to attain early success within a reasonable timeframe.” Russel Young has been named President of the new entity and majority shareholder Mike Brown has been name Secretary and Director. “This is a great opportunity, and I too am excited about our relationship with Right on Brands Inc.” states Russel. About Us Right on Brands, Inc., is a consumer goods company specializing in the brand development and distribution of hemp-based foods, beverages, smokables, oils and topical products. Right on Brands, Inc. is a developer of a broad line of hemp-based smokables, beverages, tinctures, and topical products including products infused with CBD, Delta-8, Delta-10, THCV, CBDV, and Delta-9 (below the federal limit) and the all new HHC vapes, gummies and tinctures. We will also be launching a Kratom gummy. About ENDO Brands: ENDO Brands™, Humbly Hemp®, and ENDO Dispensary & Wellness™ Endo Franchise Group Inc, all share the same goal of providing our customers with the best products in the health and wellness space. As the field of health and wellness Endo’s approach is to give their customer a holistic approach to their wellness. To learn more, please visit: https://rightonbrands.com / www.endobrands.com / www.ENDOdispensaryrowlett.com Corporate Sales Contact: Mike Brown (214) 299-9528 / mike@rightonbrands.com ENDO Brands Corporate Store: ENDO Brands at Lakeview Plaza 6501 Dalrock Road Suite 100 Rowlett, Texas 75089 214-299-9528 AUSTIN LOCATION 12412 Limerick Avenue, Austin, Texas 78758 www.endoofaustin.com 512-621-0649 LAREDO LOCATION ENDO Laredo 2413 Jacaman Rd Laredo, Texas www.endolaredo.com 956-568-2300 HOUSTON LOCATION 3301 Louetta Rd Ste 109 Spring, Texas 77388 832-583-5383 (Website coming soon) MIAMI FLORIDA LOCATION 10850 SW 104 th St, Miami, Florida 33156 www.endo-miami.com 786-703-1276 PLANO LOCATION 601 W. Parker Road, Plano, Texas 75023 469-366-9694 DALLAS LOCATION 9585 Scyene Road, Dallas. Texas, (Website coming soon) Forward-Looking Statements This press release contains information that constitutes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All such forward-looking statements involve risk and uncertainties that could cause actual results to differ materially from any future results described by the forward-looking statements. Risk factors that could contribute to such differences include those matters more fully disclosed in the Company's reports filed with the SEC. The forward-looking information provided herein represents the Company's estimates as of the date of this press release, and subsequent events and developments may cause the Company’s estimates to change. The Company specifically disclaims any obligation to update the forward-looking information in the future. Therefore, this forward-looking information should not be relied upon as representing the Company's estimates of its future financial performance as of any date subsequent to the date of this press release. Investor Relations Contact Andrew Barwicki 516-662-9461 / andrew@barwicki.com Contact Details Mike Brown mike@rightonbrands.com Company Website https://rightonbrands.com/

April 12, 2023 09:00 AM Eastern Daylight Time

1 ... 113114115116117 ... 248